Form 4 for HCA HCA Healthcare
Accepted 2023-02-01 00:00:00 ET · period of report 2023-01-30 · accession 0001209191-23-006039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-02-01 | 2023-02-01 | HCA | Paslick P. Martin | SVP, CIO | S - Sale | $256.95 | -1,000 | 3,000 | -25% | -$256.9K |
| D | 2023-02-01 | 2023-01-30 | HCA | Paslick P. Martin | SVP, CIO | A - Grant | $0.00 | +9,472 | 9,472 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | S | D | 1,000 | $256.95 | 3,000 | I by 2021 Trust | — | — | |
| 2 | Derivative | Stock Appreciation Right | 2023-01-30 | A | A | 9,472 | $0.00 | 9,472 | D | $253.30 · 2024-01-30 to 2033-01-30 | 9,472 Common Stock | (F1) The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. |